Our additional experiments indicated that SFT2D2‐TBX19 overexpression promoted cell proliferation, migration and invasion (Figure 1H,I and Figure S1F, Supporting Information), revealing that SFT2D2‐TBX19 may play an oncogenic role in prostate tumor development. This evidence concerns the gene SFT2D2 and prostate neoplasm.